FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and can be used to induce or accelerate healing of skin damages or skin wounds. That is ensured by introduction of an agent used to simulate expression and/ or activity of at least one PKC isoform in dermal cells colonising a damaged skin or a skin wound area. It is combined with introduction of at least one agent specified from insulin, growth factor, adipokin, PKC RACK and GW9662. Therefore, appropriate pharmaceutical compositions for local application are used.
EFFECT: inventions ensure fast wound closure, accelerate scarring due to synergetic effect of said products in combination.
39 cl, 5 tbl, 27 ex, 43 dwg
Title | Year | Author | Number |
---|---|---|---|
METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR WOUND HEALING | 2008 |
|
RU2404799C2 |
METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR WOUND HEALING | 2004 |
|
RU2491952C2 |
WAYS AND PHARMACOLOGICAL COMPOSITIONS FOR HEALING OF WOUNDS | 2004 |
|
RU2359694C2 |
PHARMACEUTICAL COMPOSITIONS AND WOUND HEALING ACCELERATION TECHNIQUES | 2004 |
|
RU2358753C2 |
APPLICATION OF ADIPOCYTES, PRE-ADIPOCYTES AND STEM CELLS FOR INDUCTION OR ACCELERATION OF WOUND HEALING AND PHARMACEUTICAL COMPOSITION, CONTAINING THEM | 2009 |
|
RU2419441C2 |
INDOLYLMALEIMIDE DERIVATIVES | 2005 |
|
RU2373201C2 |
PHARMACEUTICAL COMPOSITION AND RELATED METHODS | 2008 |
|
RU2502520C2 |
THERAPEUTIC USE OF OXIDATIVE HYPOTONIC ACID SOLUTIONS | 2020 |
|
RU2822544C2 |
METHOD FOR BIOTECHNOLOGICAL SKIN RECOVERY WITH HUMAN ALLOGENIC HUMAN STEM CELLS | 2017 |
|
RU2687007C2 |
METHOD OF IDENTIFICATION OF INHIBITORS OR AGONISTS OF PROTEIN KINASE IRS | 2004 |
|
RU2340898C2 |
Authors
Dates
2010-06-27—Published
2004-07-15—Filed